Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of resistance to KRAS<sup>G12C</sup> inhibitor in a non-small cell lung cancer responder.

Journal of genetics and genomics = Yi chuan xue bao·2026
Same author

Remote mobilization of gut Tregs exosomes serves as nanoshuttles for targeted cardioprotection against ischemia/reperfusion injury by ginseng polysaccharides.

Pharmacological research·2026
Same author

Systematic profiling of human gut bacteria with cyclic di-AMP secretion to enhance anti-tumor immunity.

Journal of advanced research·2026
Same author

Regulating Sodium Vacancy and Local Coordination Structure Enabled Stable Mn-Based NASICON Cathodes.

Angewandte Chemie (International ed. in English)·2025
Same author

Learning to Detect Sleep Micro-Events From Coarse Sleep Stage Annotations.

IEEE journal of biomedical and health informatics·2025
Same author

The artificial chemical Y21 serves as a GA-signaling agonist and an auxin analog to promote seed germination and root development.

Journal of integrative plant biology·2025

Related Experiment Video

Updated: Dec 17, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K

Artificial intelligence-based collaborative filtering method with ensemble learning for personalized lung cancer

Shengda Luo1, Jiahui Xu2, Zebo Jiang2

  • 1Faculty of Information Technology, Macau University of Science and Technology, Macau (SAR), China.

Pharmacological Research
|June 27, 2020
PubMed
Summary

This study introduces a cost-effective ensemble learning method for personalized medicine, recommending non-small-cell lung cancer (NSCLC) treatments without genetic data. The approach efficiently identifies suitable compounds, reducing costs and experimental efforts.

Keywords:
Ensemble learningNon-small-cell lung cancerPersonalized medicineRecommender system

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.9K
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

1.1K

Related Experiment Videos

Last Updated: Dec 17, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.9K
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

1.1K

Area of Science:

  • Computational biology
  • Pharmacogenomics
  • Machine learning in medicine

Background:

  • Personalized medicine requires selecting optimal compounds for non-small-cell lung cancer (NSCLC) patients, a process often hindered by high costs and complex decision-making.
  • Existing methods for drug compound selection can be expensive and time-consuming, particularly for rare cancer types or when genetic data is limited.

Purpose of the Study:

  • To develop a computationally efficient and cost-effective collaborative filtering method using ensemble learning for personalized compound selection in NSCLC.
  • To enable effective drug recommendations for NSCLC patients even in the absence of genetic data.
  • To construct a novel dataset for evaluating drug response in NSCLC.

Main Methods:

  • A collaborative filtering approach integrated with ensemble learning was employed to address small sample sizes in drug response datasets.
  • The method was designed to identify suitable compounds without relying on patient genetic information.
  • A new dataset comprising eight NSCLC cell lines and ten FDA-approved compounds was created for validation.

Main Results:

  • Experimental results confirmed the absence of dataset shift, a common issue in biomedical data.
  • The proposed ensemble learning method demonstrated superior performance compared to two state-of-the-art recommender systems on both the NCI60 and the newly constructed datasets.
  • The method successfully identified effective compound recommendations without utilizing genetic data.

Conclusions:

  • The developed method offers a cost-effective and efficient solution for personalized compound selection in NSCLC treatment.
  • This approach facilitates drug sensitivity prediction, potentially reducing the need for extensive laboratory experiments.
  • It represents a novel strategy for personalized medicine, particularly valuable when genetic data is unavailable.